Skip to main content
. 2018 Apr 23;13(4):e0196109. doi: 10.1371/journal.pone.0196109

Table 2. Commonly prescribed chronic oral medications in older long-stay nursing home residents.

Medication ATC Code# ATC System/major category Women (Per cent receiving) Men
(Per cent receiving)
Sex Effect (p) Age Effect (p) Odds ratio^ Age Women Odds ratio^ Age Men
Acetaminophen N02BE01 Nervous/analgesic 33.8 26.4 0.001 0.006 ns ns
Aspirin B01AC06 Blood/antithrombotic 32.7 36.3 0.01 0.87 ns ns
Furosemide C03CA01 Cardiovascular/diuretic 29.9 28.0 ns < .001 1.06* 1.09*
Potassium A12BA Alimentary/mineral supplements 24.2 18.7 <0.001 0.03 ns ns
L-Thyroxine H03AA01 Hormonal/thyroid 23.7 11.5 <0.001 < .001 ns 1.13*
Lisinopril C09AA03 Cardiovascular/renin-angiotensin system 14.2 14.1 ns < .001 0.94* 0.88**
Metoprolol C07AB02 Cardiovascular/beta blocking 14.2 17.7 <0.001 < .001 ns 0.90*
Donepezil N06DA02 Nervous-dementia 13.2 13.9 ns 0.71 ns ns
Citalopram N06AB04 Nervous/antidepressant 13.1 12.7 ns < .001 0.91** ns
Digoxin C01AA05 Cardiovascular/cardiac therapy 11.3 10.9 ns < .001 1.14** 1.13*
Mirtazepine N06AX11 Nervous/antidepressant 10.9 8.7 <0.01 0.001 ns ns
Amlopdipine C08CA01 Cardiovascular/calcium channel blocker 10.3 8.9 ns 0.06 ns 0.88*
Warfarin B01AA03 Blood/antithrombotic 9.7 11.3 ns 0.003 0.92* ns
Clopidogrel B01AC04 Blood/antithrombotic 9.7 10.8 ns 0.001 0.92* ns
Sertraline N06AB06 Nervous/antidepressant 9.6 9.7 ns 0.12 ns ns
Ranitidine A02BA02 Alimentary/acid-related disorders 9.6 10.3 ns 0.64 ns ns
Pantoprazole A02BC02 Alimentary/acid-related disorders 9.6 8.6 ns 0.02 0.93* ns
Lansoprazole A02BC03 Alimentary/acid-related disorders 8.9 10.3 ns < .001 0.89** ns
Hydrochlorothiazide C03AA03 Cardiovascular-diuretic 8.8 6.9 <0.01 0.22 ns ns
Olanzapine N05AH03 Nervous/psycholeptic 8.3 8.6 ns < .001 0.88** ns
Quetapine N05AH04 Nervous/psycholeptic 6.1 8.2 <0.01 < .001 0.91* ns
Risperidone N05AX08 Nervous/psycholeptic 7.9 8.1 ns 0.004 0.91* ns
Celecoxib MO1AH Musculoskeletal/anti-inflammatory 7.8 5.9 <0.01 0.39 ns ns
Atenolol C07FB03 Cardiovascular/beta-blocking 7.7 6.9 ns 0.89 ns ns
Omeprazole A02BC01 Alimentary/acid-related disorders 7.3 7.3 ns 0.93 ns ns
Isosorbide C01DA08 Cardiovascular/cardiac therapy 7.2 6.6 ns 0.39 ns ns
Lorazepam N05CD06 Nervous/psycholeptic 6.9 5.7 ns < .001 0.87** ns
Hydrocodone N02AA08 Nervous/analgesic 6.9 5.3 <0.01 < .001 0.86** ns
Atorvastatin C10AA05 Cardiovascular/lipid-lowering 6.8 8.4 ns < .001 0.71** 0.81**
Calcitonin H05BA01 Hormone/calcium homeostatis 5.9 1.8 <0.001 < .001 1.08 1.32*
Gabapentin N03AX12 Nervous/anti-seizure 5.7 5.7 ns < .001 0.80** 0.91
Diltiazem C08DB01 Cardiovascular/calcium channel blocker 5.6 4.6 ns 0.29 0.94 1.01
Paroxetine N06AB05 Nervous/antidepressant 5.6 4.9 ns 0.82 0.99 0.96
Carbidopa N04BA02 Nervous/antiparkinson 5.1 8.4 <0.001 < .001 0.81** 0.94
L-Dopa NO4BA01 Nervous/antiparkinson 4.5 6.9 <0.001 < .001 0.82** 0.96
Risedronate M05BA07 Musculoskeletal/bone 4.8 1.0 <0.001 0.23 0.98 0.95
Trazodone N06AX05 Nervous/antidepressant 4.5 4.8 ns 0.12 0.93 1.01
Phenytoin N03AB02 Nervous/anti-seizure 4.0 6.4 <0.001 < .001 0.76** 0.76**
Memantine N06DX01 Nervous-dementia 4.0 5.0 ns 0.04 0.93 1.01
Divalproex N03AG01 Nervous/anti-seizure 3.7 5.8 <0.001 < .001 0.73** 0.83**
Glipizide A10BB07 Alimentary-diabetes 3.6 5.4 <0.001 < .001 0.8** 0.95

#ATC = Anatomical Therapeutic Chemical Classification system.

^ Odds ratio for age considered as a continuous variable.

* p-value ≤0.01.

** p-value ≤0.001